Evidation
Founded Year
2012Stage
Series E | AliveTotal Raised
$259.18MValuation
$0000Last Raised
$153M | 4 yrs agoMosaic Score The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.
-46 points in the past 30 days
About Evidation
Evidation focuses on harnessing real-world health data to measure and improve health outcomes. The company offers a digital health measurement and engagement platform that utilizes data science and machine learning to provide health guidance, treatments, and tools. Evidation primarily serves life sciences companies, government bodies, and academic institutions. It was founded in 2012 and is based in San Mateo, California.
Loading...
ESPs containing Evidation
The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.
The electronic clinical outcome assessment (eCOA) market offers digital platforms that enable patients to directly report their health outcomes. These tools use tablets, smartphones, and web applications to collect data on symptoms, side effects, and quality of life. By capturing data in real-time, eCOA solutions enhance the accuracy and reliability of patient-reported outcomes. These platforms st…
Evidation named as Leader among 15 other companies, including IQVIA, Medidata, and Medable.
Evidation's Products & Differentiators
Research
Evidation runs programs for enterprises to get actionable evidence in three areas: disease burden and patient impact, patient segmentation and identification, disease event and progression modelling. We deploy a proven approach, incorporating our experience with over 200 research programs, to reliably delivers results. Given our connectivity with highly engaged individuals, we deliver faster and more cost-effectively.
Loading...
Research containing Evidation
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Evidation in 7 CB Insights research briefs, most recently on Aug 21, 2024.
Expert Collections containing Evidation
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Evidation is included in 6 Expert Collections, including Unicorns- Billion Dollar Startups.
Unicorns- Billion Dollar Startups
1,249 items
Digital Health 50
300 items
The most promising digital health startups transforming the healthcare industry
Value-Based Care & Population Health
1,260 items
The VBC & Population Health collection includes companies that enable and deliver care models that address the health needs for defining populations along the continuum of care, including in the community setting, through participation, engagement, and targeted interventions.
Digital Health
11,109 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Telehealth
3,106 items
Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.
Precision Medicine Tech Market Map
160 items
This CB Insights Tech Market Map highlights 160 precision medicine companies that are addressing 9 distinct technology priorities that pharmaceutical companies and healthcare providers face.
Evidation Patents
Evidation has filed 9 patents.
The 3 most popular patent topics include:
- wearable devices
- machine learning
- smartwatches
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
1/18/2023 | 10/15/2024 | Bobsleigh, luge, and skeleton tracks, Machine learning, Wearable devices, Learning, Business intelligence | Grant |
Application Date | 1/18/2023 |
|---|---|
Grant Date | 10/15/2024 |
Title | |
Related Topics | Bobsleigh, luge, and skeleton tracks, Machine learning, Wearable devices, Learning, Business intelligence |
Status | Grant |
Latest Evidation News
Oct 18, 2024
News provided by Share this article www.evidation.com In this free webinar, discover how real-world data can revolutionize our understanding of depression and drive more patient-centered research and care. Attendees will learn how longitudinal collection of active and passive real-world data from 54,000+ individuals with depression helps paint a more comprehensive picture of the day-to-day experiences and challenges of living with this mental health condition. The featured speaker will look at depression-related patterns and trends by combining patient-reported experiences with objective metrics like activity, sleep and heart rate from wearables, as well as share insights about depression and its management, including how to shape treatment priorities, enhance clinical trial design, and inform personalized care strategies. TORONTO, Oct. 18, 2024 /PRNewswire-PRWeb/ -- To better address the impact of depression on the well-being and quality of life, treatment approaches and clinical trials can benefit from information about the everyday experiences and challenges of individuals with depression. Equally important is understanding how these experiences change over time and with treatment. Gaining these insights relies on longitudinal data collected from a large, representative, real-world population, which can be difficult to achieve in clinical trial and care settings. A continuous, direct connection to an online community of engaged individuals willing to respond to surveys and connect their devices and apps, such as Apple Watches and Fitbits, presents opportunities to capture data longitudinally. These novel, layered datasets help accurately and comprehensively describe the real-world experiences with depression. A continuous, direct connection to an online community of engaged individuals willing to respond to surveys and connect their devices and apps, such as Apple Watches and Fitbits, presents opportunities to capture data longitudinally. Using this approach, Evidation collected survey data from over 54,000 individuals and sleep and activity data from more than 35,000 individuals who had a wearable device connected in the past 90 days. Join Christian Cerrada, Lead Health Behavior Scientist at Evidation , to learn how this rich dataset can help you: Better understand the day-to-day experiences and challenges of living with depression Uncover depression-related patterns and trends by combining patient-reported experiences with objective metrics like activity, sleep and heart rate from wearables Segment study populations by characteristics such as treatment non-compliance, treatment switchers and treatment resistance Create a more complete view of depression and its management, offering new opportunities to shape treatment priorities, enhance clinical trial design and inform personalized care strategies ABOUT XTALKS Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers. To learn more about Xtalks visit https://xtalks.com For information about hosting a webinar visit https://xtalks.com/why-host-a-webinar/ Contact:
Evidation Frequently Asked Questions (FAQ)
When was Evidation founded?
Evidation was founded in 2012.
Where is Evidation's headquarters?
Evidation's headquarters is located at 63 Bovet Road, San Mateo.
What is Evidation's latest funding round?
Evidation's latest funding round is Series E.
How much did Evidation raise?
Evidation raised a total of $259.18M.
Who are the investors of Evidation?
Investors of Evidation include B Capital, McKesson Ventures, Kaiser Permanente Ventures, OMERS Private Equity, SV Health Investors and 12 more.
Who are Evidation's competitors?
Competitors of Evidation include Tempus, Science 37, Money Walk, AllStripes, TriNetX and 7 more.
What products does Evidation offer?
Evidation's products include Research.
Loading...
Compare Evidation to Competitors
ObvioHealth is a company focused on providing digital health solutions, specifically in the realm of decentralized clinical trials. The company offers a suite of services including digital trial design, remote patient monitoring, virtual site services, and integration of sensors and wearable devices. It's platform, ObvioGo, and accompanying services such as electronic patient-reported outcomes (ePRO), electronic consent (eConsent), and clinical outcome assessments (eCOA) streamline the clinical trial process for sponsors and participants. It was founded in 2017 and is based in New York, New York.
Medable specializes in providing digital clinical trial software solutions within the healthcare and pharmaceutical sectors. The company offers a comprehensive platform that facilitates the management of clinical trials, including tools for remote data collection, electronic consent (eConsent), patient-reported outcomes (ePRO), and clinical outcome assessments (eCOA), all designed to streamline the trial process and enhance data quality. Medable was formerly known as Dermatrap. It was founded in 2012 and is based in Palo Alto, California.
Holmusk is a data analytics and health technology company focused on behavioral health. The company offers a real-world evidence platform that leverages AI-powered analytics and digital solutions to improve research and care in behavioral health. Holmusk's main services include providing access to a comprehensive behavioral health database, advanced data analytics software, and an electronic health records platform designed for psychiatry practices. It was founded in 2015 and is based in New York, New York.
Owkin operates as an artificial intelligence (AI)-based biotechnology company. It utilizes AI to enhance the process of finding suitable treatments for patients. The company's main services include the use of AI to identify new treatments, accelerate clinical trials, and build diagnostic tools. It enables researchers in hospitals, universities, and the biopharmaceutical industry to understand how drug efficacy varies for the improvement of drug development. Its services primarily cater to the biopharmaceutical and academic research sectors. It was founded in 2016 and is based in New York, New York.
Aetion operates as a healthcare analytics company. It provides decision-grade real-world evidence solutions to biopharma companies, payers, and regulatory agencies. It offers a platform that analyzes data from the real world to produce scientifically validated answers on treatments, effectiveness, and value. The company was founded in 2012 and is based in New York, New York.
Datavant operates as a company focused on health data connectivity in the healthcare industry. It offers services that securely and compliantly connect patient-level health data, providing solutions for data and analytics, life sciences, providers, government agencies, research networks, and health plans. Its primary customers are organizations within the healthcare sector. The company was founded in 2017 and is based in San Francisco, California.
Loading...